SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan · Delayed Price · Currency is TWD 19.70
-0.50 (-2.48%)
Jul 14, 2026, 1:33 PM CST
TPEX:4192 Market Cap
TPEX:4192 has a market cap or net worth of 692.74 million as of July 14, 2026. Its market cap has decreased by -29.39% in one year.
Market Cap
692.74M
Enterprise Value
551.42M
Revenue
27.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.70
Market Cap Chart
Since August 29, 2013, TPEX:4192's market cap has decreased from 3.70B to 692.74M, a decrease of -81.26%. That is a compound annual growth rate of -12.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 692.74M | -20.88% |
| Dec 31, 2025 | 875.60M | -28.55% |
| Dec 31, 2024 | 1.23B | -9.24% |
| Dec 29, 2023 | 1.35B | -53.80% |
| Dec 30, 2022 | 2.92B | -20.00% |
| Dec 30, 2021 | 3.65B | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 997.31M |
| GeneReach Biotechnology | 979.88M |
| TCI GENE | 978.96M |
| Meribank Biotech | 964.56M |
| Taiwan Advance Bio-Pharmaceutical | 891.90M |
| NatureWise Biotech & Medicals | 834.71M |
| BioLASCO Taiwan | 752.99M |
| MegaPro Biomedical | 737.82M |